There is a lot of information out there about HIV research, and although most of that information is good, some can be misleading. We want to share a few important facts about research and HIV prevention.
Knowledge and education are power and we want to turn it up.
Got a burning question? Email us at firstname.lastname@example.org and we’ll hit you back with an answer. We may even feature your question in a knowledge article!
Scientific research has produced important social benefits and health improvements such as development of vaccines for polio and treatments for HIV. However, scientific research has also raised troubling ethical questions. Probably the most infamous example in the U.S. Read more>>
The Human Immunodeficiency Virus (HIV) is a virus that attacks the immune system, or the part of your body that works to keep you healthy by fighting off infections. Over time, and without treatment, HIV can cause Acquired Immunodeficiency Syndrome (AIDS), as the Read more>>
In the US, there have been approximately 50,000 new HIV infections every year for more than a decade according to the Centers for Disease Control and Prevention. Do the math. Gay, bisexual, and other men who have sex with men (MSM) account for about 2% of the US Read more>>
The AMP Study (also known as HVTN 704/HPTN 085) tests an experimental antibody against HIV. AMP stands for Antibody Mediated Prevention. This is the idea of giving people antibodies that fight HIV to see if they will protect people from becoming infected with Read more>>
Learn more about the AMP (Antibody Mediated Prevention) study and how it fits within the landscape of HIV prevention research in these four videos produced by the HIV Vaccine Trials Network & Bridge HIV Read more>>
Myth: HIV vaccines can give people HIV.
Fact: This statement is false: a person CANNOT get HIV from the study vaccines because these study vaccines do not contain real HIV. Some vaccines, like those for typhoid or Read more>>
In 2012, the U.S. Food and Drug Administration (FDA) approved Truvada for use in HIV prevention, a strategy known as pre-exposure prophylaxis, or PrEP. Bridge HIV’s Director of HIV Prevention Intervention Studies, Dr. Albert Liu, talks about this important HIV Read more>>
One of the most common concerns people have about HIV vaccine research is around vaccine–induced Seropositivity, or VISP. So besides being a mouthful, what is VISP? And can it affect me? When our bodies encounter a foreign substance, like a virus, our immune Read more>>
June 27th is National HIV Testing Day (NHTD) in the U.S. Held annually since 1995, the event promotes HIV testing, early diagnosis, and treatment as a critical component of HIV prevention initiatives around the country. Since the early 1980s, HIV/AIDS has claimed the Read more>>